Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DHODH | Q02127 | 19/20 | 0.56 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19631478 | 0.92 | DHODH (0.66) | DHODHKDM4EALDH1A1POLBMAPT | |
| SCHEMBL19634183 | 0.83 | DHODH (0.67) | DHODH | |
| SCHEMBL19634074 | 0.81 | DHODH (0.61) | DHODHKDM4EALDH1A1POLBMAPT | |
| SCHEMBL19631421 | 0.76 | DHODH (0.95) | DHODHKDM4EALDH1A1POLBMAPT | |
| SCHEMBL30131172 | 0.76 | DHODH (0.95) | DHODHKDM4EALDH1A1POLBMAPT | |
| SCHEMBL19631385 | 0.76 | DHODH (0.93) | DHODHKDM4EALDH1A1POLBMAPT | |
| SCHEMBL30131121 | 0.76 | DHODH (0.93) | DHODHKDM4EALDH1A1POLBMAPT | |
| SCHEMBL19631459 | 0.75 | DHODH (0.84) | DHODHKDM4EALDH1A1POLBMAPT | |
| SCHEMBL21394319 | 0.74 | DHODH (0.81) | DHODHKDM4EALDH1A1POLBMAPT | |
| SCHEMBL19631467 | 0.74 | DHODH (1.00) | DHODHKDM4EALDH1A1POLBMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2017198179-A1 | APPLICATIONS OF NOVEL THIAZOLE DERIVATIVE IN TREATING INFLAMMATORY BOWEL DISEASES | 华东理工大学 | 2017-11-23 | — | — | WO | disclosed |
| WO-2017198178-A1 | THIAZOLE DERIVATIVE AND APPLICATIONS | 华东理工大学 | 2017-11-23 | — | — | WO | disclosed |